tirzepatide mounjaro New Blockbuster Type 2 Medication Gets FDA Approval Welcome to Mounjaro® (tirzepatide injection)

van Puijenbroek et al., 2002)

When you activate GLP-1 receptors in your stomach and brain, the medication signals satiety earlier during meals, reduces cravings between eating periods, and may improve insulin sensitivity

* This self-assessment is for informational purposes only and does not constitute medical advice

Various cell types express GLP-1 receptor (GLP-1R) including pancreatic alpha, beta and delta cells, neurons of the central nervous system (particularly hypothalamus and brain stem), endothelial cells, smooth muscle cells in blood vessels, cardiomyocytes and various regions of the gastrointestinal (GI) tract [19,20]